BackMinerva Surgical Overview

Minerva Surgical Current Cash

Minerva Surgical's current cash is $11M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$11.13M
26.38% YoYΔ $-3.99M vs prior year quarter

Peer average

Loading

Minerva Surgical Current Cash History

Loading

Minerva Surgical vs. peers: Current Cash Comparison

Loading

Minerva Surgical Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Minerva Surgical (UTRS) FAQ

The latest current cash for UTRS is $11M as of September 2023. That compares with $15M in the prior-year period — down 26.4% year over year. Investors often review this figure alongside Minerva Surgical's historical trend and sector peers before judging valuation or financial health.

Over the past year, UTRS's current cash moved from $15M to $11M — a 26.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Minerva Surgical's operating scale or balance-sheet position.

A current cash figure of $11M for UTRS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting UTRS's current cash ($11M), review year-over-year change from $15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Minerva Surgical's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.